Promoting research partnerships to improve veterans’ health

NAVREF is proud to recognize Cohen Veterans Bioscience as our Champion Sponsor

USAMRAA’s Supplemental Guidance on Administrative Flexibilities for Grants and Cooperative Agreements in Response to COVID-19 Pandemic

27 Mar 2020 1:20 PM | Hawk Tran (Administrator)

On March 19, 2020 OMB issued Memorandum M-20-17 Administrative Relief for Recipients and Applicants of Federal Financial Assistance Directly Impacted by the Novel Coronavirus (COVID-19) due to Loss of Operations (https://www.whitehouse.gov/wp-content/uploads/2020/03/M-20-17.pdf). The Department of Defense (DoD) also recently published Frequently Asked Questions (FAQs) (https://basicresearch.defense.gov/COVID-19/Frequently-Asked-Questions/). The United States Army Medical Research Acquisition Activity (USAMRAA) will apply, to the maximum extent possible, all the allowed exceptions to our financial assistance awards, including allowance of costs. The following exceptions, aligned with the format in Memorandum M-20-17 and guidance from the DoD, are time limited. OMB anticipates reassessing the exceptions within 90 days.

 

1. Flexibility with SAM registration:

 

  • The SAM registration process will be relaxed as outlined in M-20-17.

 

2. Flexibility with application deadlines:

 

  • There are currently no plans to modify existing application deadline dates but please continue to monitor Grants.gov for any potential change(s) to an application deadline.
  • Please contact the CDMRP Help Desk at help@eBRAP.org or 301-682-5507 if you need further assistance.
  • This response may be updated at a later date depending on whether application review panel meeting dates are revised. Please check this page periodically for possible updates.

 

3. Waiver of Notice of Funding Opportunities Publication:

 

  • USAMRAA has no immediate emergency Program Announcements for grants or cooperative agreements available at this time.
  • This response may be updated at a later date depending on whether application review panel meeting dates are revised. Please check this page periodically for possible updates.

 

4. No-cost extensions on expiring awards:

 

  • USAMRAA’s terms and conditions of award already allow for a one-time, no cost extension of up to 12 months, without need to request prior approval, when the recipient notifies the Grants Officer (GO).
  • Recipients may notify USAMRAA’s GO(s) of a blanket no-cost extension on all active awards(including grant numbers) covered under M-20-17 -- i.e., they do not need to be requested on an individual basis for each award.
  • However, please be aware that funding expiration statutes may prohibit extensions. Recipients should contact the USAMRAA GO for award-specific guidance.

 

5. Abbreviated continuation requests:

 

  • Not applicable for USAMRAA grants and cooperative agreements.

 

6. Expenditure of award funds for salaries and other project activities:

 

  • Recipients may continue to charge salaries and benefits to currently active awards consistent with the recipients' policy of paying salaries (under unexpected or extraordinary circumstances) from all funding sources, Federal and non-Federal.
  • USAMRAA will allow other costs to be charged to Federal awards necessary to resume activities supported by the award, consistent with applicable Federal cost principles and the benefit to the project. This may include allowing rent on equipment and facilities during this time frame.

oHowever, to the maximum extent practicable, recipients must invoke or institute any and all reasonable mitigation actions and practices to lessen the cost to the Government during the crisis period. Such actions may be part of an existing program created by the recipient organization or may be created to respond to this crisis.

  • Recipients must maintain appropriate records and cost documentation as required by 2 CFR §200.302 - Financial management and 2 CFR § 200.333 - Retention requirement of records to substantiate the charging of any salaries and other project activities costs related to interruption of operations or services.

 

7. Allowability of Costs not Normally Chargeable to Awards.

 

  • USAMRAA will allow recipients who incur costs related to the cancellation of events, travel, or other activities necessary and reasonable for the performance of the award, or the pausing and restarting of grant funded activities due to the public health emergency, to charge these costs to their award without regard to 2 CFR § 200.403, Factors affecting allow ability of costs, 2 CFR §200.404, Reasonable costs, and 2 CFR § 200.405, Allocable costs.
  • USAMRAA will allow recipients to charge full cost of cancellation when the event, travel, or other activities are conducted under the auspices of the grant.
  • However, recipients should not assume additional funds will be available should the charging of cancellation or other fees result in a shortage of funds to eventually carry out the event or travel.
  • Recipients are required to maintain appropriate records and cost documentation as required by2 CFR § 200.302 - Financial management and 2 CFR § 200.333 Retention requirement of records, to substantiate the charging of any cancellation or other fees related to interruption of operations or services.

 

8. Prior approval requirement waivers:

 

  • OMB and DoD have authorized awarding agencies to waive prior approval requirements as necessary. Some prior approvals are already waived under the DoD General Research &Development Terms and Conditions and USAMRAA’s agency-specific terms conditions.
  • Recipients should consult their GO regarding other potential prior approval waivers based on project-specific circumstances.
  • All costs charged to Federal awards must be consistent with Federal cost policy guidelines and the terms of the award, except where specified in OMB Memorandum M-20-17.

 

9. Exemption of certain procurement requirements:

 

  • The procurement requirements contained in 2 CFR 200.319(b) regarding geographic preference and 2 CFR 200.231 regarding contracting with small and minority businesses, women’s business enterprises, and labor surplus supply firms are waved in order to expedite the procurement process for needed support during the period outlined in OMB Memorandum M-20-17.

 

10. Extension of financial and other reporting:

 

  • Recipients may delay submission of financial, performance and other reports on currently active award accounts up to three (3) months beyond the normal due date.
  • Contact the GO and Grants Officer’s Representative (GOR) for extensions on other milestones and deliverables required in the terms and conditions of the award. If warranted, the same three-month extension may be granted.
  • Recipients may continue to invoice for payment of Federal funds without timely submission of reports.
  • Reports must be submitted at the end of the postponed period. Additional extensions require prior approval of the GO.

 

11. Extension of currently approved indirect costs rates:

 

  • Recipients may continue to use the currently approved indirect cost rates (i.e., predetermined, fixed, or provisional rates) to recover their indirect costs on Federal awards.
  • Recipients may contact their cognizant agency for indirect costs to request an extension on the use of the current rates for one additional year without submission of an indirect cost proposal. The cognizant agency may also approve requests for an extension of the indirect cost rate proposal submission to finalize the current rates and establish future rates.

 

12. Extension of closeout:

 

  • Recipients may delay submission of any pending financial, performance and other reports required by the terms of the award for the closeout of expired projects, provided that proper notice about the reporting delay is given by the grantee to the GO.
  • This delay in submitting closeout reports may not exceed one year after the award expires.

 

13. Extension of Single Audit submission.

 

  • Implemented as stated in M-20-17.

 

14. The COVID-19 pandemic has impacted the conduct of my DoD-supported human subjects research protocol. What do I need to report to the USAMRDC Human Research Protection Office (HRPO)?

 

 

15. ACURO Guidance During the COVID-19 Pandemic

 


1717 K ST NW Suite 900

Washington, DC 20006

P: 301-656-5005  |  admin@navref.org

Powered by Wild Apricot Membership Software